Please login to the form below

Not currently logged in
Email:
Password:

Sanofi to buy Universal Medicare's OTC unit

According to reports, Sanofi is in talks to buy the majority stake in Universal Medicare's over-the-counter (OTC) business

According to reports, Sanofi is in talks to buy the majority stake in Universal Medicare's over-the-counter (OTC) business.

News agency Reuters has said two sources with 'direct knowledge' of the subject claim India-based Aventis Pharma, a division of Sanofi, is close to completing a deal worth 5bn rupees ($109.5m).

The deal would see Aventis gain 30 products manufactured by Universal Medicare, with combined annual sales of over 1bn rupees, boosting the company's OTC activities in India.

Universal Medicare has a workforce of around 700 people. Its OTC products include pain management medicines and cod-liver oil.

Sanofi refused to comment on the speculation.

23rd August 2011

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
StratX

StratX creates experiential learning programs instilled with emotion and competitive spirit, leading to lasting on-the-job change. Our memorable approach develops...

Latest intelligence

Island
Pharma’s isolated islands of innovation
With service design and technology often failing the patient, why perspective on improving outcomes need to change...
Uncertainty, austerity and Brexit
What does it mean for the life science sector?...
The Holy Grail of HCP Access
This is the data you need to gain access....

Infographics